Upon arriving in Bethesda, Maryland on Monday, September 19; my only expectation was to learn a lot about ASHP policy to help keep the SSHP chapter at Campbell University’s College of Pharmacy and Health Sciences better informed. As the orientation began on Monday afternoon, those expectations were drastically changed upon the realization that the room was full of some of the most go-getter type of pharmacists from all over the country. The introductions that were begun at orientation continued during the opening reception and helped me quickly understand the significance of being invited to attend ASHP Policy Week. There were residency directors, deans of pharmacy schools, health-system pharmacists, new practitioners, student pharmacists, ASHP staff, and members of ASHP’s Board of Directors gathering to discuss and begin to draft policy for ASHP. Although the reception was casual in nature and formally brought to order in a comical manner by ASHP President Stan Kent, the importance of being part of this gathered group became more and more apparent.
Introductions during dinner with the members of the Council on Public Policy helped to form the team that would come together over the next few days to work on developing the policy items that will eventually go before the ASHP Board of Directors or the House of Delegates at the 2012 Summer Meeting in Baltimore. The development of our team was begun as Chair of the Council on Public Policy, Amber Lucas, used an icebreaker to really help all the council members to get to know each other better. With the team formed, the stage was set to begin the real work of ASHP Policy Week.
Over the next two days in a meeting room in the Hyatt, the Council on Public Policy discussed several policies assigned to the council. From the state licensing of pharmacy technicians to a statement on confidentiality of patient healthcare information, each policy item brought before the council was thoroughly presented by the council members with background and other relevant material emphasized. On a personal note, my assignment of presenting information on the statement on confidentiality of patient healthcare was not only very appropriate for me as a former pharmaceutical sales representative when HIPAA went into effect, it was interesting to relate the emergence of electronic records and identity theft to the official ASHP statement. After presentations of each policy item, there was lively and informative discussion about each item and what action needed to be taken by the Council on Public Policy regarding future actions on the each topic. Being employed as a pharmaceutical sales representative in the community and a hospital sales specialist in the past, my personal vantage point for some of the policies was a little different than the average student pharmacist. This perspective enabled me to offer some insights into some of the policies that were directly related to issues involving the pharmaceutical industry or hospital contracts with pharmaceutical companies. In fact, this past industry experience was beneficial while working on the policy regarding biosimilar interchangeability with another council member, Dr. Mitchell Pelter, to finalize the wording to be brought before the ASHP House of Delegates at the 2012 Summer Meeting.
Overall, the experience of reviewing, discussing, drafting, and sometimes tabling policy items was an eye-opening and invigorating experience that has whet my appetite for future work with ASHP policy councils. In addition, the William A. Zellmer lecture presented by Jimmy R. Mitchell was another aspect of ASHP Policy Week that gave me motivation to work even harder to become an oncology pharmacist that makes a difference in the lives of cancer patients as part of a collaborative team. Mr. Mitchell’s question to students about what can be done to ensure collaborative efforts become a standard of care led me to answer, “Do not allow current students to know anything else.” This objective is being met by pharmacy school faculty throughout the United States and it is encouraging to know that leadership in ASHP is proactive in making sure that the goal of collaborative health teams which include pharmacists is considered the standard of care.
Beyond the council meetings and luncheon lecture with Mr. Mitchell, the reception on Tuesday night allowed us all to better understand the work of ASHP staff and the great things they do to help all of us who are student pharmacists and those who are health-system pharmacists. This was yet another time to better understand the caliber of people at ASHP Policy Week and their roles in advancing the profession of pharmacy. The contacts made during this week of developing policy have already proven to be key in helping pave the way for me to reach my goal of becoming an oncology pharmacist. This experience just added more proof that pharmacy is a small world and the people who are part of this small world want nothing more than for the profession to advance, especially through current student pharmacists who will become pharmacy leaders in the near future.
Then came the icing on the cake: Legislative Day. All of us were energized by Senator Klobuchar and ASHP President Stan Kent before beginning our visits on Capitol Hill. With three other members of the delegation from North Carolina, visits were made to the offices of Senator Burr and Senator Hagan. Although not a practicing pharmacist dealing with the drug shortages firsthand, I am a breast cancer survivor who is passionate about other women not being able to get the recommended treatment for their breast cancers. While discussing the drug shortage situation with Senator Burr’s aide, emotions bubbled to the surface as I recalled being treated with Adriamycin and Cytoxan while pregnant and how pregnant women today may be facing a situation where these drugs are not available and time for treatment is very time-sensitive. Hopefully my perspective added to the already gained knowledge about the drug shortages and put a story and a face to the situation.
Hearing the key points iterated from the lead of the NC delegation, Dr. Larry Buie, and another leading member, Dr. Paul Bush, to the aides of Senators Burr and Hagan enabled me to emphasize them better when meeting with Congresswoman Ellmers’ aide. As a whole, it was a great day on Capitol Hill and one where the voice of pharmacists and student pharmacists were heard loud and clear.
All in all, the experience of being a third year pharmacy student at ASHP Policy Week is best described as phenomenal, yet words cannot adequately describe the experience. I am humbled to know that I had the honor of being amongst the thought leaders in the world of health-system pharmacy and the opportunity to join them in helping to develop future ASHP policy. Therefore, missing four days of lectures in therapeutics, jurisprudence, and biostats and returning to a therapeutics case presentation on Friday morning was well worth the benefits of attending ASHP Policy Week.